Literature DB >> 12531732

Age-dependent increase in hydrogen peroxide production by cardiac monoamine oxidase A in rats.

Agnès Maurel1, Carole Hernandez, Oksana Kunduzova, Guy Bompart, Claudie Cambon, Angelo Parini, Bernard Francés.   

Abstract

Oxidative stress is one of the factors involved in age-related impairment of cardiac function. In the present study, we investigated the role of the catecholamine-degrading enzyme monoamine oxidase (MAO) in H(2)O(2) production in the hearts of young, adult, and old rats. MAO-dependent H(2)O(2) production, measured by a chemiluminescence-based assay, increased with age, reaching the maximum in 24-mo-old rats (7.5-fold increase vs. 1-mo-old rats). The following observations indicate that the age-dependent increase in H(2)O(2) generation was fully related to the MAO-A isoform: 1) at all the ages tested, chemiluminescence production was inhibited by the MAO-A inhibitor clorgyline but not by the MAO-B inhibitor RO-19 6327; 2) enzyme assay, Western blot, and semiquantitative RT-PCR analysis showed an age-dependent increase in cardiac MAO-A activity, immunodetection, and mRNA expression, respectively; and 3) the MAO-B isoform was undetectable by enzyme assay and Western blot analysis. These results suggest that MAO-A could be a major source of H(2)O(2) in the aging heart.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12531732     DOI: 10.1152/ajpheart.00700.2002

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  45 in total

Review 1.  Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury.

Authors:  Nina Kaludercic; Andrea Carpi; Roberta Menabò; Fabio Di Lisa; Nazareno Paolocci
Journal:  Biochim Biophys Acta       Date:  2010-09-24

Review 2.  Mitochondria and cardioprotection.

Authors:  Fabio Di Lisa; Marcella Canton; Roberta Menabò; Nina Kaludercic; Paolo Bernardi
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

Review 3.  Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases.

Authors:  Dale E Edmondson; Claudia Binda; Jin Wang; Anup K Upadhyay; Andrea Mattevi
Journal:  Biochemistry       Date:  2009-05-26       Impact factor: 3.162

Review 4.  Exercise preconditioning of the myocardium.

Authors:  Andreas N Kavazis
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

5.  Platelet monoamine oxidase-A activity and aging: effect of carnosine.

Authors:  S Banerjee; M K Poddar
Journal:  J Physiol Sci       Date:  2013-05-09       Impact factor: 2.781

Review 6.  Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release.

Authors:  Dmitry B Zorov; Magdalena Juhaszova; Steven J Sollott
Journal:  Physiol Rev       Date:  2014-07       Impact factor: 37.312

7.  p53-PGC-1α pathway mediates oxidative mitochondrial damage and cardiomyocyte necrosis induced by monoamine oxidase-A upregulation: role in chronic left ventricular dysfunction in mice.

Authors:  Christelle Villeneuve; Céline Guilbeau-Frugier; Pierre Sicard; Olivier Lairez; Catherine Ordener; Thibaut Duparc; Damien De Paulis; Bettina Couderc; Odile Spreux-Varoquaux; Florence Tortosa; Anne Garnier; Claude Knauf; Philippe Valet; Elisabetta Borchi; Chiara Nediani; Abdallah Gharib; Michel Ovize; Marie-Bernadette Delisle; Angelo Parini; Jeanne Mialet-Perez
Journal:  Antioxid Redox Signal       Date:  2012-08-10       Impact factor: 8.401

Review 8.  New insights on receptor-dependent and monoamine oxidase-dependent effects of serotonin in the heart.

Authors:  J Mialet-Perez; P Bianchi; O Kunduzova; A Parini
Journal:  J Neural Transm (Vienna)       Date:  2007-04-30       Impact factor: 3.575

Review 9.  Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection.

Authors:  D Morin; R Assaly; S Paradis; A Berdeaux
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 10.  Cardiac aging and insulin resistance: could insulin/insulin-like growth factor (IGF) signaling be used as a therapeutic target?

Authors:  Sihem Boudina
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.